Dean Laganosky, M.D., named Urology Trailblazer for 2024

Author(s):

Key Takeaways

Dr. Dean Laganosky received the 2024 Trailblazer Award from LUGPA for significant contributions to urology within his first decade of practice.
At 37, Dr. Laganosky has pioneered advanced urologic treatments, including Bioprotect, Optilume, SpaceOAR, and Aquablation.
MidLantic Urology, with over 60 physicians, is a leading provider known for clinical research and state-of-the-art technology across 46 locations.
The award highlights Dr. Laganosky's innovation, leadership, and commitment to advancing urology and improving patient care.

This prestigious recognition is given to one urologist or administrator each year who has significantly contributed to the field of urology within the first ten years of their practice.

Philadelphia, November 15, 2024 - Dr. Dean Laganosky, urologist with MidLantic Urology, has been awarded the 2024 Trailblazer Award by the Large Urology Group Practice Association (LUGPA), a trade association representing 153 urology groups in the U.S.

Dean Laganosky, MD

This prestigious recognition is given to one urologist or administrator each year who has significantly contributed to the field of urology within the first ten years of their practice. The award acknowledges the winner’s exceptional achievements, innovation, leadership in urology, and commitment to advancing the field.

Among a field of worthy recipients, Dr. Laganosky was selected for his pioneering spirit, his contributions to MidLantic Urology in Southeast Pennsylvania, and his help breaking new ground in patient care.

At just 37 years of age and in practice for just 5 years, Dr. Laganosky’s career accomplishments are remarkable. They include pioneering work with cutting-edge urologic treatments, including Bioprotect, Optilume, SpaceOAR, and Aquablation. He is passionate about educating his colleagues and patients and is a true trailblazer in the field.

Watch Dr. Laganosky’s remarks.

About MidLantic Urology

MidLantic Urology is one of the country’s largest and most innovative providers, combining top urology specialists with clinical research and state-of-the-art technology. The group has more than 60 physicians working in 46 locations throughout Philadelphia and surrounding counties. It pioneers research and establishes nationally recognized centers of excellence focused on subspecialties, including prostate cancer, kidney stones, and female pelvic medicine. To learn more about MidLantic Urology, visit midlanticurology.com.